Zobrazeno 1 - 10
of 573
pro vyhledávání: '"ROXANIS, I."'
Autor:
Harvey-Jones, E., Raghunandan, M., Robbez-Masson, L., Magraner-Pardo, L., Alaguthurai, T., Yablonovitch, A., Yen, J., Xiao, H., Brough, R., Frankum, J., Song, F., Yeung, J., Savy, T., Gulati, A., Alexander, J., Kemp, H., Starling, C., Konde, A., Marlow, R., Cheang, M., Proszek, P., Hubank, M., Cai, M., Trendell, J., Lu, R., Liccardo, R., Ravindran, N., Llop-Guevara, A., Rodriguez, O., Balmana, J., Lukashchuk, N., Dorschner, M., Drusbosky, L., Roxanis, I., Serra, V., Haider, S., Pettitt, S.J., Lord, C.J., Tutt, A.N.J.
Publikováno v:
In Annals of Oncology April 2024 35(4):364-380
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Azad A; Department of Oncology, The Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Institute of Genomic and Cancer Sciences, Vincent Drive, University of Birmingham, Birmingham, UK.; Comprehensive Cancer Centre, Kings' College London, London, UK., Arshad M; Institute of Genomic and Cancer Sciences, Vincent Drive, University of Birmingham, Birmingham, UK.; Comprehensive Cancer Centre, Kings' College London, London, UK., Generali D; U.O. Multidisciplinare di Patologia Mammaria, U.S Terapia Molecolare e Farmacogenomica, A.O. Instituti Ospitalieri di Cremona, Viale Concordia 1, Cremona, Italy., Feldinger K; Department of Oncology, The Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Gijsen M; Department of Oncology, The Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Strina C; U.O. Multidisciplinare di Patologia Mammaria, U.S Terapia Molecolare e Farmacogenomica, A.O. Instituti Ospitalieri di Cremona, Viale Concordia 1, Cremona, Italy., Cappelletti M; U.O. Multidisciplinare di Patologia Mammaria, U.S Terapia Molecolare e Farmacogenomica, A.O. Instituti Ospitalieri di Cremona, Viale Concordia 1, Cremona, Italy., Andreis D; U.O. Multidisciplinare di Patologia Mammaria, U.S Terapia Molecolare e Farmacogenomica, A.O. Instituti Ospitalieri di Cremona, Viale Concordia 1, Cremona, Italy.; Biostatistics and Clinical Trials Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Forlì-Cesena, Meldola, Italy., Leek R; Department of Oncology, The Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Haider S; Department of Oncology, The Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; The Institute of Cancer Research, London, UK., Kellokumpu-Lehtinen PL; Department of Oncology, Tampere University Hospital and Tampere University, Tampere, Finland., Roxanis I; The Institute of Cancer Research, London, UK.; Department of Cellular Pathology, Oxford University Hospitals and Oxford Biomedical Research Centre, Oxford, UK., Harris AL; Department of Oncology, The Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Shaaban AM; Department of histopathology, Queen Elizabeth Hospital Birmingham, Birmingham, UK., Joensuu H; Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Kong A; Department of Oncology, The Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Institute of Genomic and Cancer Sciences, Vincent Drive, University of Birmingham, Birmingham, UK.; Comprehensive Cancer Centre, Kings' College London, London, UK.
Publikováno v:
Cancer communications (London, England) [Cancer Commun (Lond)] 2024 Nov 24. Date of Electronic Publication: 2024 Nov 24.
Autor:
Yoneyama M; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Zormpas-Petridis K; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Robinson R; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Sobhani F; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Provenzano E; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Steel H; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Lightowlers S; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Towns C; Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Castillo SP; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Anbalagan S; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Lund T; Integrated Pathology Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Wennerberg E; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Melcher A; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Coles CE; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Roxanis I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Yuan Y; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom. Electronic address: YYuan6@mdanderson.org., Somaiah N; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden NHS Foundation Trust, London, United Kingdom. Electronic address: navita.somaiah@icr.ac.uk.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Nov 01; Vol. 120 (3), pp. 862-874. Date of Electronic Publication: 2024 Apr 26.
Autor:
Cheung A; Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom.; St. John's Institute of Dermatology, School of Basic and Medical Biosciences & KHP Centre for Translational Medicine, King's College London, Guy's Hospital, London, United Kingdom., Chenoweth AM; Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom.; St. John's Institute of Dermatology, School of Basic and Medical Biosciences & KHP Centre for Translational Medicine, King's College London, Guy's Hospital, London, United Kingdom., Johansson A; Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom.; Cancer Bioinformatics, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom., Laddach R; St. John's Institute of Dermatology, School of Basic and Medical Biosciences & KHP Centre for Translational Medicine, King's College London, Guy's Hospital, London, United Kingdom.; Department of Informatics, Faculty of Natural, Mathematical and Engineering Sciences, King's College London, London, United Kingdom., Guppy N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Trendell J; Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom., Esapa B; St. John's Institute of Dermatology, School of Basic and Medical Biosciences & KHP Centre for Translational Medicine, King's College London, Guy's Hospital, London, United Kingdom., Mavousian A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Navarro-Llinas B; Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom., Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Romero-Clavijo P; St. John's Institute of Dermatology, School of Basic and Medical Biosciences & KHP Centre for Translational Medicine, King's College London, Guy's Hospital, London, United Kingdom., Hoffmann RM; St. John's Institute of Dermatology, School of Basic and Medical Biosciences & KHP Centre for Translational Medicine, King's College London, Guy's Hospital, London, United Kingdom.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Andriollo P; Institute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Rahman KM; Institute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Jackson P; Institute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Tsoka S; Department of Informatics, Faculty of Natural, Mathematical and Engineering Sciences, King's College London, London, United Kingdom., Irshad S; Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom., Roxanis I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Grigoriadis A; Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom.; Cancer Bioinformatics, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom., Thurston DE; Institute of Pharmaceutical Science, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Lord CJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Tutt ANJ; Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Karagiannis SN; Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, United Kingdom.; St. John's Institute of Dermatology, School of Basic and Medical Biosciences & KHP Centre for Translational Medicine, King's College London, Guy's Hospital, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 01; Vol. 30 (15), pp. 3298-3315.
Autor:
Mannion J; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Gifford V; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Bellenie B; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Fernando W; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Ramos Garcia L; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Wilson R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., John SW; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Udainiya S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Patin EC; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Tiu C; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Smith A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Goicoechea M; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Craxton A; MRC Toxicology Unit, University of Cambridge, Gleeson Building, Cambridge CB2 1QR, UK., Moraes de Vasconcelos N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Guppy N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Cheung KJ; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Cundy NJ; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Pierrat O; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Brennan A; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Roumeliotis TI; Functional Proteomics Group, The Institute of Cancer Research, London SW3 6JB, UK., Benstead-Hume G; Functional Proteomics Group, The Institute of Cancer Research, London SW3 6JB, UK., Alexander J; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Muirhead G; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Layzell S; Institute of Immunity and Transplantation, University College London, London NW3 2PP, UK., Lyu W; Department of Immunology and Microbiology, LEO Foundation Skin Immunology Research Center, University of Copenhagen, Copenhagen, Denmark., Roulstone V; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Allen M; Biological Services Unit, The Institute of Cancer Research, London SW3 6JB, UK., Baldock H; Biological Services Unit, The Institute of Cancer Research, London SW3 6JB, UK., Legrand A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Gabel F; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Serrano-Aparicio N; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Starling C; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Guo H; Department of Microbiology and Immunology, LSU Health Shreveport, Shreveport, LA, USA., Upton J; Department of Biological Sciences, Auburn University, Auburn, AL, USA., Gyrd-Hansen M; Department of Immunology and Microbiology, LEO Foundation Skin Immunology Research Center, University of Copenhagen, Copenhagen, Denmark., MacFarlane M; MRC Toxicology Unit, University of Cambridge, Gleeson Building, Cambridge CB2 1QR, UK., Seddon B; Institute of Immunity and Transplantation, University College London, London NW3 2PP, UK., Raynaud F; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Roxanis I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Harrington K; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Choudhary JS; Functional Proteomics Group, The Institute of Cancer Research, London SW3 6JB, UK., Hoelder S; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Tenev T; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK. Electronic address: tencho.tenev@icr.ac.uk., Meier P; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK. Electronic address: pmeier@icr.ac.uk.
Publikováno v:
Immunity [Immunity] 2024 Jul 09; Vol. 57 (7), pp. 1514-1532.e15. Date of Electronic Publication: 2024 May 23.
Autor:
Dillon MT; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Guevara J; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Mohammed K; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Patin EC; The Institute of Cancer Research, London, United Kingdom., Smith SA; Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Dean E; Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Jones GN; Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Willis SE; Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Petrone M; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom., Silva C; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom., Thway K; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Bunce C; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Roxanis I; The Institute of Cancer Research, London, United Kingdom., Nenclares P; The Institute of Cancer Research, London, United Kingdom., Wilkins A; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom., McLaughlin M; The Institute of Cancer Research, London, United Kingdom., Jayme-Laiche A; UCL Cancer Institute and University College London Hospital NHS Foundation Trust, London, United Kingdom., Benafif S; UCL Cancer Institute and University College London Hospital NHS Foundation Trust, London, United Kingdom., Nintos G; King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom., Kwatra V; King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom., Grove L; The Institute of Cancer Research, London, United Kingdom., Mansfield D; The Institute of Cancer Research, London, United Kingdom., Proszek P; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Martin P; Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Moore L; Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Swales KE; The Institute of Cancer Research, London, United Kingdom., Banerji U; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Saunders MP; The Christie NHS Foundation Trust, Manchester, United Kingdom., Spicer J; King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom., Forster MD; UCL Cancer Institute and University College London Hospital NHS Foundation Trust, London, United Kingdom., Harrington KJ; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2024 Jan 16; Vol. 134 (2). Date of Electronic Publication: 2024 Jan 16.
Autor:
Fitzpatrick A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Iravani M; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Mills A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Vicente D; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Alaguthurai T; Breast Cancer Now Research Unit, Guy's Hospital, King's College London, London, UK., Roxanis I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Turner NC; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Tutt ANJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Breast Cancer Now Research Unit, Guy's Hospital, King's College London, London, UK.; Oncology and Haematology Directorate, Guy's and St Thomas' NHS Foundation Trust, London, UK., Isacke CM; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. clare.isacke@icr.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2023 Nov 16; Vol. 14 (1), pp. 7408. Date of Electronic Publication: 2023 Nov 16.
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tovey H; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Sipos O; Breast Cancer Now Toby Robinsons Research Centre, The Institute of Cancer Research, London, United Kingdom., Parker JS; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Hoadley KA; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Quist J; The Breast Cancer Now Unit, King's College London Faculty of Life Sciences and Medicine, London, United Kingdom.; School of Cancer and Pharmaceutical Sciences, King's College London Faculty of Life Sciences and Medicine, London, United Kingdom., Kernaghan S; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Kilburn L; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Salgado R; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium., Loi S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia., Kennedy RD; ALMAC Diagnostic Services, Northern Ireland, United Kingdom., Roxanis I; Breast Cancer Now Toby Robinsons Research Centre, The Institute of Cancer Research, London, United Kingdom., Gazinska P; Breast Cancer Now Toby Robinsons Research Centre, The Institute of Cancer Research, London, United Kingdom.; Biobank Research Group, Lukasiewicz Research Network - PORT Polish Center for Technology Development, Wroclaw, Poland., Pinder SE; School of Cancer and Pharmaceutical Sciences, King's College London Faculty of Life Sciences and Medicine, London, United Kingdom., Bliss J; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Perou CM; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Haider S; Breast Cancer Now Toby Robinsons Research Centre, The Institute of Cancer Research, London, United Kingdom., Grigoriadis A; The Breast Cancer Now Unit, King's College London Faculty of Life Sciences and Medicine, London, United Kingdom.; School of Cancer and Pharmaceutical Sciences, King's College London Faculty of Life Sciences and Medicine, London, United Kingdom., Tutt A; Breast Cancer Now Toby Robinsons Research Centre, The Institute of Cancer Research, London, United Kingdom.; The Breast Cancer Now Unit, King's College London Faculty of Life Sciences and Medicine, London, United Kingdom.; School of Cancer and Pharmaceutical Sciences, King's College London Faculty of Life Sciences and Medicine, London, United Kingdom., Cheang MCU; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Sep 15; Vol. 29 (18), pp. 3691-3705.